Showing 591-600 of 20377 results for "".
Survodutide in Obesity: Insights from SYNCHRONIZE-1
https://reachmd.com/programs/clinicians-roundtable/survodutide-obesity-synchronize-1/57029/New findings from the SYNCHRONIZE-1 trial reveal that survodutide's impact extends beyond weight reduction, with a demonstrated decrease in liver fat and meaningful improvements across multiple markers of metabolic health in patients without type 2 diabetes. Dr. Carel le Roux joins us to share the eTwo Types of Tax-Advantaged Benefit Plans: Why Aesthetic Practices Should Consider Both
https://reachmd.com/topics/practice-development/two-types-of-tax-advantaged-benefit-plans-why-aesthetic-practices-should-consider-both/35155/A look at ways to reduce taxes an increase retirement savingsDiabetes Highlights from ENDO 2013 - the 95th Annual Meeting of The Endocrine Society
https://reachmd.com/programs/conference-coverage/diabetes-highlights-from-endo-2013-the-95th-annual-meeting-of-the-endocrine-society/6823/Diabetes Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. In this program, you will hear from global thought leadersCan Autologous Stem Cells Reverse the Damage of a Heart Attack?
https://reachmd.com/programs/heart-matters/can-autologous-stem-cells-reverse-the-damage-of-a-heart-attack/5258/Stem cell therapies across multiple disciplines continue to demonstrate promising results. How successful are autologous cardiac stem cell treatments proving to be at regenerating cardiac tissue after a heart attack? Which patients would be the best candidates for this procedure, and when might thisUse of Glucagon and Insulin in a Closed-Loop System
https://reachmd.com/programs/diabetes-discourse/use-of-glucagon-and-insulin-in-a-closed-loop-system/6259/The latest research into the use of glucagon and insulin in a closed-loop system is promising for the management of type 1 diabetes. How will the use of a bihormonal system benefit patients, and what is the path of treatment? Join host Dr. Steven Edelman and his guests, associate professor of biomedUsing Video Games to Improve Children’s Diets
https://reachmd.com/programs/diabetes-discourse/using-video-games-to-improve-childrens-diets/6294/How are video games showing promise as a behavior change strategy to improve children's diets? Newly-funded video-game programs are specifically designed to lower risk of type 2 diabetes and obesity in children. Join host Dr. Steven Edelman and his guest, professor of pediatrics at Baylor College,What is the Relationship Between Insulin Sensitivity and Puberty?
https://reachmd.com/programs/diabetes-discourse/what-is-the-relationship-between-insulin-sensitivity-and-puberty/5755/The emergence of type 2 diabetes in both children and adolescents suggests a relationship between insulin sensitivity and puberty. What are we learning from recent studies and clinical research? Join host Dr. Steven Edelman and his guest, professor of pediatrics at the University of Colorado, Dr. PhEmerging Insulin Pump Technology
https://reachmd.com/programs/diabetes-discourse/emerging-insulin-pump-technology/5108/Will insulin pumps become the preferred therapy for patients with type 2 diabetes who are not at goal? New insulin pump technology and patch pumps are offering a whole new level of customization, an ability to improve glucose control and quality of life. Join host Dr. Steven Edelman and his guest, e"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
https://reachmd.com/programs/the-convergence/data-barriers-ai-smarter-faster-care/39923/From streamlining research to informing real-time decisions, AI-powered platforms are beginning to reshape how clinicians and researchers access and apply data in patient care. Learn more as Dr. Brian McDonough speaks with Matt Newman, Senior Vice President of Industry Solutions at Manifold, about hGetting to Know GRADE: A Comparative Study of T2D Treatment
https://reachmd.com/programs/diabetes-discourse/getting-to-know-grade-a-comparative-study-of-t2d-treatment/14216/An ancillary study from the landmark GRADE study explores the efficacy of different treatments for type 2 diabetes. What do we need to know about them?